Company description

Quotient Sciences has over 30 years of experience in small molecule drug development, supporting clients from candidate selection to commercial supply. We’re experts in formulating simple and complex oral and inhaled drug products, with a broad range of manufacturing technologies and high-potency handling capabilities.

Our services include: Formulation Development, Clinical Trial Manufacturing, Commercial Manufacturing, Clinical Pharmacology, and Translational Pharmaceutics®, which accelerates development by integrating formulation development, real-time manufacturing and clinical testing.  This integrated approach is proven to reduce timelines by more than 12 months and lower R&D costs by more than $100 million. Whether you need an integrated development plan or standalone formulation and manufacturing services, connect with Quotient Sciences to discover how we can accelerate the development of your molecule: www.quotientsciences.com/contactus

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: Analytical Chemistry |Analytical Methods |Bioavailability enhancement More

Upcoming events

9 sep 2020

CPhI North America 2020

9 - 11 Sep 2020 Philadelphia, USA Visit us at stand 1130 Book a meeting See our Exhibitor Profile   See full Exhibitor List

News about Quotient Sciences

Tufts CSDD Demonstrates Multi-Million Dollar Benefits of Translational Pharmaceutics®

21 Feb 2020

Tufts CSDD Demonstrates Multi-Million Dollar Benefits of Translational Pharmaceutics®

Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&D costs by more than $100 million per approved new drug, compared to traditional multi-vendor development paradigms.

Read more
Quotient Sciences

Contact information




View all contact information